Please login to the form below
commissioning
This page shows the latest commissioning news and features for those working in and with pharma, biotech and healthcare.
NICE recommends Sanofi and Regeneron’s Libtayo for advanced CSCC
NICE’s decision means eligible patients will be able to gain full NHS access to the drug in England via routine commissioning. ... from interim CDF funding into routine NHS commissioning, a move that ensures eligible patients in England have long-term
Latest news
-
Seagen’s Tukysa granted NICE recommendation for breast cancer patients
Peter Martin, country medical director, UK &Ireland at Seagen, added the “positive decision from NICE, making the tucatinib combination available for baseline NHS commissioning, is a real step-change for
-
NICE sets out plans for ‘ambitious’ five-year strategy
systems as a priority in organising and commissioning local services.
-
NICE recommends Roche’s Polivy for B-cell lymphoma
thousands more lives already being saved thanks to improving treatment,” said John Stewart, NHS director of Specialised Commissioning.
-
NHS England will make PrEP for HIV available in April
Routine commissioning is needed urgently to increase access and provide much needed certainty to those on the trial,” commented the NAT’s chief executive Deborah Gold.
-
Celgene’s Revlimid scores NICE approval in follicular lymphoma
However, Revlimid will become immediately accessible with interim funding provided via the Cancer Drugs Fund, until the final guidance is published and the funding switches to routine commissioning budgets.
More from news
Approximately 1 fully matching, plus 251 partially matching documents found.
Latest Intelligence
-
Assessing the impact of disease prevalence on access and pricing of rare disease drugs in England
focus on the single technology appraisal [STA] and the highly specialised technology [HST] frameworks), or, second, via NHS England specialised commissioning. ... 80.9%; 17/21) compared with drugs evaluated by NHS England for specialised commissioning (61
-
Evolution or revolution: the latest review of NICE methods
A NICE style of review. In what is a hallmark of NICE’s approach to reviews, it will be commissioning work from others on different components of the review.
-
25 Women Leaders in UK Healthcare (part 2)
Greater Manchester Health and Social Care partnership, formed in 2016, has pooled resources from local authorities, hospitals and Clinical Commissioning Groups (CCGs) to create a single £6bn budget to provide integrated ... One of the region’s
-
The Orkambi row explained
NHS England's Specialised commissioning head John Stewart says this was because NHSE was new then and just finding its feet.
-
The Orkambi blame game
NICE’s chief executive Sir Andrew Dillon and NHS England’s John Stewart, national director, specialised commissioning, were both on hand to argue that Vertex had been exceptionally ‘inflexible’ in its
More from intelligence
Approximately 1 fully matching, plus 44 partially matching documents found.
Latest appointments
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
In that role, she provided strategic insight on NHS policies, commissioning and reimbursement pathways.
-
Prof Sir Mike Richards joins Incisive Health as senior counsel
In July 2012 he was appointed as Director for Reducing Premature Mortality on the NHS Commissioning Board (now NHS England), where he led the development of a cardiovascular outcomes strategy.
-
NHiS appoints mental health associate director
Laurence Mascarenhas joins the Commissioning Excellence division. NHiS has appointed Laurence Mascarenhas as an associate director of its mental health support service. ... Previously, Mascarenhas was service development and commissioning manager at NHS
-
New NHS CEO announces senior changes
Further appointments to this programme will be announced in time. Elsewhere, Ian Dodge was appointed to the NHS England board as national director for commissioning strategy.
-
Pfizer’s Emms takes up ABPI presidency
its companies in issues such as the value-based pricing debate and the implementation of a new NHS commissioning system in England.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Call for industry innovators to join working group
compliance and regulation. - clinical research. - change management. - clinical commissioning. -
-
Is COVID-19 yet another barrier to contraceptive access?
NHS England, clinical commissioning groups (CCGs) and local authorities,.
-
CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
roles. The demise of Clinical Commissioning Groups (CCGs) and the development of Integrated Care Systems (ICSs) will, over the coming months, see thousands of NHS professionals taking on new roles within
-
5 Reasons To Add Character Animation To Your Next Campaign.
Whether it's repurposing them for social media or commissioning a new animation, your assets are already designed and ready to go.
-
Understanding the role of provider collaboratives
How will this affect prescribing? One effect of Clinical Commissioning Groups (CCGs) being absorbed or merged into ICSs will be a reduction in Area Prescribing Committees (APCs). ... While certain services, including some specialised commissioning, will
More from PMHub
Approximately 1 fully matching, plus 68 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Eli Lilly to make bebtelovimab commercially available to US states from August
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Achieving communication excellence by targeting the right channel at the right time
- Oral biologics delivery still elusive
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
PMHub
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
